NYSE - Nasdaq Real Time Price USD

Ventas, Inc. (VTR)

Compare
62.53 -0.04 (-0.06%)
At close: October 4 at 4:00 PM EDT
63.01 +0.48 (+0.77%)
After hours: October 4 at 5:32 PM EDT
Loading Chart for VTR
DELL
  • Previous Close 62.57
  • Open 62.13
  • Bid 61.33 x 1100
  • Ask 62.53 x 800
  • Day's Range 61.72 - 62.60
  • 52 Week Range 39.34 - 65.65
  • Volume 2,446,604
  • Avg. Volume 2,554,200
  • Market Cap (intraday) 25.934B
  • Beta (5Y Monthly) 1.39
  • PE Ratio (TTM) --
  • EPS (TTM) -0.37
  • Earnings Date Oct 30, 2024
  • Forward Dividend & Yield 1.80 (2.88%)
  • Ex-Dividend Date Oct 1, 2024
  • 1y Target Est 65.24

Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,350 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 800 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. The Company aims to deliver outsized performance by leveraging its unmatched operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

www.ventasreit.com

486

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VTR

View More

Performance Overview: VTR

Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VTR
28.80%
S&P 500
20.57%

1-Year Return

VTR
61.47%
S&P 500
35.98%

3-Year Return

VTR
24.66%
S&P 500
31.99%

5-Year Return

VTR
4.13%
S&P 500
97.59%

Compare To: VTR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VTR

View More

Valuation Measures

Annual
As of 10/4/2024
  • Market Cap

    25.93B

  • Enterprise Value

    38.76B

  • Trailing P/E

    --

  • Forward P/E

    217.39

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.42

  • Price/Book (mrq)

    2.70

  • Enterprise Value/Revenue

    8.22

  • Enterprise Value/EBITDA

    20.00

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.33%

  • Return on Assets (ttm)

    1.67%

  • Return on Equity (ttm)

    -1.44%

  • Revenue (ttm)

    4.71B

  • Net Income Avi to Common (ttm)

    -156.87M

  • Diluted EPS (ttm)

    -0.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    557.08M

  • Total Debt/Equity (mrq)

    134.16%

  • Levered Free Cash Flow (ttm)

    868.95M

Research Analysis: VTR

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 1.19B
Earnings 19.39M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

55.00 Low
65.24 Average
62.53 Current
73.00 High
 

Company Insights: VTR

Research Reports: VTR

View More
  • US REIT Sector Offers Relatively Stable Internal Growth

    Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

    Rating
    Price Target
     
  • Despite Recent Rally, Many REITs in the US Are Trading at Discounts to Fair Value Estimate

    Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

    Rating
    Price Target
     
  • Ventas Earnings: High NOI Growth and High Acquisition Cap Rates for Senior Housing Segment

    Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

    Rating
    Price Target
     
  • Below average yield and no dividend increase since COVID

    Ventas Inc. is a real estate investment trust that invests primarily in real estate serving the healthcare sector. The company acquires, develops, leases, and manages about 1,400 senior housing and medical office properties in the U.S., Canada, and the U.K. Currently, with about 800 senior housing properties, the segment accounts for just under 60% of VTR's property count and about half of NOI. Medical office and research assets account for about 30% of the portfolio with approximately 32 million square feet of space. These offices are located in 31 states, and about 95% are affiliated with hospitals or health systems. The company acquired 153 new properties in 1H23 in a loan-to-own transaction. The company was founded in 1998 as a spinoff of Vencor, a healthcare services company. VTR also has an asset management business (VIM) with $5 billion under management. VTR shares are a component of the S&P 500. The company's market cap is $25 billion.

    Rating
    Price Target
     

People Also Watch